Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Pfarr

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Research|February 28, 2001
Differential binding of the Menin tumor suppressor protein to JunD isoformsO Yazgan, C M Pfarr
The Journal of Cell Biology|November 1, 1991
Mitotic motorsJ R McIntosh, C M Pfarr
Oncogene|February 20, 1997
Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblastsD Lallemand, G Spyrou, M Yaniv, et al.
Oncogene|February 20, 1997
Transformation by ras modifies AP1 composition and activityF Mechta, D Lallemand, C M Pfarr, et al.
Oncogene|July 1, 1994
Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell lineC Francastel, R Groisman, C M Pfarr, et al.
Cell|February 25, 1994
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by rasC M Pfarr, F Mechta, G Spyrou, et al.
Molecular and Cellular Biology|May 1, 1996
Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalizationL Vandel, N Montreau, E Vial, et al.
Oncogene|August 1, 1993
In vitro transforming capacities of mouse c-jun:junD chimeric genesC Métivier, F Piu, C M Pfarr, et al.
Oncogene|February 2, 1995
Increased transforming activity of JunB and JunD by introduction of an heterologous homodimerization domainL Vandel, C M Pfarr, S Huguier, et al.
Journal of Cell Science|January 14, 1998
The glucocorticoid receptor and AP-1 are involved in a positive regulation of the muscle regulatory gene myf5 in cultured myoblastsF Auradé, C M Pfarr, C Lindon, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Research|February 28, 2001
Differential binding of the Menin tumor suppressor protein to JunD isoformsO Yazgan, C M Pfarr
The Journal of Cell Biology|November 1, 1991
Mitotic motorsJ R McIntosh, C M Pfarr
Oncogene|February 20, 1997
Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblastsD Lallemand, G Spyrou, M Yaniv, et al.
Oncogene|February 20, 1997
Transformation by ras modifies AP1 composition and activityF Mechta, D Lallemand, C M Pfarr, et al.
Oncogene|July 1, 1994
Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell lineC Francastel, R Groisman, C M Pfarr, et al.
Cell|February 25, 1994
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by rasC M Pfarr, F Mechta, G Spyrou, et al.
Molecular and Cellular Biology|May 1, 1996
Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalizationL Vandel, N Montreau, E Vial, et al.
Oncogene|August 1, 1993
In vitro transforming capacities of mouse c-jun:junD chimeric genesC Métivier, F Piu, C M Pfarr, et al.
Oncogene|February 2, 1995
Increased transforming activity of JunB and JunD by introduction of an heterologous homodimerization domainL Vandel, C M Pfarr, S Huguier, et al.
Journal of Cell Science|January 14, 1998
The glucocorticoid receptor and AP-1 are involved in a positive regulation of the muscle regulatory gene myf5 in cultured myoblastsF Auradé, C M Pfarr, C Lindon, et al.
Pageof 2